Cargando…

The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study

BACKGROUND: Patient-reported outcome (PROs) measures are being used more frequently in investigational studies of treatments for moderate to severe plaque psoriasis. The objective of this study was to examine the relationships among the Dermatology Life Quality Index (DLQI), the Short Form 36 (SF-36...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shikiar, Richard, Willian, Mary Kaye, Okun, Martin M, Thompson, Christine S, Revicki, Dennis A
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1615869/ https://www.ncbi.nlm.nih.gov/pubmed/17005043 http://dx.doi.org/10.1186/1477-7525-4-71

Ejemplares similares

Validity and reliability of patient reported outcomes used in Psoriasis: results from two randomized clinical trials
por: Shikiar, Richard, et al.
Publicado: (2003)

Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: Results from a randomized, controlled Phase III study
por: Revicki, Dennis A, et al.
Publicado: (2008)

Minimal Important Difference (MID) of the Dermatology Life Quality Index (DLQI): Results from patients with chronic idiopathic urticaria
por: Shikiar, Richard, et al.
Publicado: (2005)

The content validity of the PSS in patients with plaque psoriasis
por: Rentz, A. M., et al.
Publicado: (2017)

Impact of brodalumab treatment on psoriasis symptoms and health-related quality of life: use of a novel patient-reported outcome measure, the Psoriasis Symptom Inventory
por: Gordon, KB, et al.
Publicado: (2014)

A history of health-related quality of life outcomes in psychiatry
por: Revicki, Dennis A., et al.
Publicado: (2014)

The impact of clinical symptoms and endoscopic and histologic disease activity on health-related quality of life in patients with ulcerative colitis following treatment with multimatrix mesalazine
por: Yarlas, Aaron, et al.
Publicado: (2021)

Development and preliminary validation of the Adolescent Psoriasis Quality of Life instrument: a disease‐specific measure of quality of life in adolescents with psoriasis
por: Randa, H., et al.
Publicado: (2020)

Translation and validation of non-English versions of the Ankylosing Spondylitis Quality of Life (ASQOL) questionnaire
por: Doward, Lynda C, et al.
Publicado: (2007)

Bioelectrical phase angle and psoriasis: a novel association with psoriasis severity, quality of life and metabolic syndrome
por: Barrea, Luigi, et al.
Publicado: (2016)

Adolescent body weight and health-related quality of life rated by adolescents and parents: the issue of measurement bias
por: Gandhi, Pranav K., et al.
Publicado: (2015)

Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2)
por: Gisondi, Paolo, et al.
Publicado: (2022)

Quality of life in patients with psoriasis
por: Bhosle, Monali J, et al.
Publicado: (2006)

Quality of life in patients with psoriasis
por: Bouhamed, M., et al.
Publicado: (2021)

Impact of Psoriasis on Quality of Life
por: Agarwal, Komal, et al.
Publicado: (2022)

Health-Related Quality of Life and Work-Related Outcomes for Patients With Mild-to-Moderate Ulcerative Colitis and Remission Status Following Short-Term and Long-Term Treatment With Multimatrix Mesalamine: A Prospective, Open-Label Study
por: Yarlas, Aaron, et al.
Publicado: (2018)

Validation of a new tool to assess health-related quality of life in psoriasis: the PSO-LIFE questionnaire
por: Dauden, Esteban, et al.
Publicado: (2012)

Changes in health-related quality of life and work-related outcomes for patients with mild-to-moderate ulcerative colitis receiving short-term and long-term treatment with multimatrix mesalamine: a prospective, open-label study
por: Willian, Mary Kaye, et al.
Publicado: (2018)

Publisher Correction: Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2)
por: Gisondi, Paolo, et al.
Publicado: (2023)

Stigmatization and Quality of Life in Patients with Psoriasis
por: Jankowiak, Barbara, et al.
Publicado: (2020)

Developing Item Banks for Measuring Pediatric Generic Health-Related Quality of Life: An Application of the International Classification of Functioning, Disability and Health for Children and Youth and Item Response Theory
por: Gandhi, Pranav K., et al.
Publicado: (2014)

Deucravacitinib in Moderate to Severe Psoriasis: Clinical and Quality-of-Life Outcomes in a Phase 2 Trial
por: Thaçi, Diamant, et al.
Publicado: (2022)

Exploring factors influencing asthma control and asthma-specific health-related quality of life among children
por: Gandhi, Pranav K, et al.
Publicado: (2013)

Three‐year efficacy and safety of certolizumab pegol for the treatment of plaque psoriasis: results from the randomized phase 3 CIMPACT trial
por: Warren, R. B., et al.
Publicado: (2021)

Quality of life information and trust in physicians among families of children with life-limiting conditions
por: Huang, I-Chan, et al.
Publicado: (2010)

Health-related quality of life improves with treatment-related GERD symptom resolution after adjusting for baseline severity
por: Revicki, Dennis A, et al.
Publicado: (2003)

In psoriasis, levels of hope and quality of life are linked
por: Hawro, Tomasz, et al.
Publicado: (2014)

General measures and quality of life issues in psoriasis
por: Sarkar, Rashmi, et al.
Publicado: (2016)

Does personality affect health-related quality of life? A systematic review
por: Huang, I-Chan, et al.
Publicado: (2017)

Improvement in Patient-Reported Outcomes (Dermatology Life Quality Index and the Psoriasis Symptoms and Signs Diary) with Guselkumab in Moderate-to-Severe Plaque Psoriasis: Results from the Phase III VOYAGE 1 and VOYAGE 2 Studies
por: Armstrong, April W., et al.
Publicado: (2018)

Assessing the Impact of Efalizumab on Nail, Scalp and Palmoplantar Psoriasis and on Quality of Life: Results from a Multicentre, Open-label, Phase IIIb/IV Trial
por: Katsambas, Andreas, et al.
Publicado: (2009)

Physical function, disease activity, and health-related quality-of-life outcomes after 3 years of adalimumab treatment in patients with ankylosing spondylitis
por: van der Heijde, Désirée M, et al.
Publicado: (2009)

Quality of life and contact with healthcare systems among patients with psoriasis and psoriatic arthritis: results from the NORdic PAtient survey of Psoriasis and Psoriatic arthritis (NORPAPP)
por: Duvetorp, A., et al.
Publicado: (2019)

Relationships between the acceptance of illness, quality of life and satisfaction with life in psoriasis
por: Kowalewska, Beata, et al.
Publicado: (2020)

Quality of life and severity of skin changes in the dynamics of psoriasis
por: Owczarek, Krzysztof, et al.
Publicado: (2016)

Illness Acceptance as the Measure of the Quality of Life in Moderate Psoriasis
por: Jankowiak, Barbara, et al.
Publicado: (2021)

Psychiatric Morbidities and Their Impact on Quality of Life in Patients With Psoriasis
por: Kumar, Abhishek, et al.
Publicado: (2023)

The Influence of Treatment Modalities on the Quality of Life of Psoriasis Patients
por: Milidrag, Ardea, et al.
Publicado: (2023)

Psychometric validation of the Female Sexual Distress Scale-Desire/Arousal/Orgasm
por: Derogatis, Leonard R., et al.
Publicado: (2021)

Relationship between vasomotor symptom improvements and quality of life and sleep outcomes in menopausal women treated with oral, combined 17β-estradiol/progesterone
por: Mirkin, Sebastian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_b1fihslpiaptn8ot14qdr7nspt